½ÃÀ庸°í¼­
»óǰÄÚµå
1589061

Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå : Á¦Ç° À¯Çü, ±â±â, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Connected Medical Devices Market by Product, Type, Device, Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 194 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 446¾ï 9,000¸¸ ´Þ·¯, 2024³â¿¡´Â 547¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 22.60%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 1,861¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Ä¿³ØÆ¼µå ÀÇ·á±â±â´Â ±âÁ¸ ÀÇ·á±â±â¿¡ ±â¼úÀ» ÅëÇÕÇÏ¿© ȯÀÚ µ¥ÀÌÅÍ ¼öÁý, Àü¼Û ¹× ºÐ¼®À» °­È­ÇÏ´Â ÇコÄɾîÀÇ Çõ½ÅÀûÀÎ Æ®·»µåÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â ÀÎÅͳݰú Ŭ¶ó¿ìµå Ç÷§ÆûÀ» ÅëÇØ °Ç°­ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ°í °øÀ¯ÇÏ¿© ȯÀÚ °á°ú¸¦ °³¼±ÇÏ°í °³ÀÎ ¸ÂÃãÇü ÀǷḦ ÃËÁøÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Çʿ伺Àº ÁÖ·Î °í·ÉÈ­ Àα¸ Áõ°¡¿Í ±×¿¡ µû¸¥ ¸¸¼º Áúȯ Áõ°¡·Î ÀÎÇØ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, ¸¸¼º Áúȯ °ü¸® ¹× Ä¡·áÀÇ Áú Çâ»ó¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í Àֱ⠶§¹®¿¡ ¹ß»ýÇÕ´Ï´Ù. ÃÖÁ¾ »ç¿ë ¹üÀ§¿¡´Â º´¿ø, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü ¹× ÀçÅÃÄ¡·á ȯ°æÀÌ Æ÷ÇԵǸç, ÀÌ·¯ÇÑ ÀåÄ¡´Â ¿¬¼Ó Æ÷µµ´ç ¸ð´ÏÅ͸µ, ¿ø°Ý ½ÉÀüµµ, Ç÷¾Ð ÃßÀû, ¿ø°Ý ÀÇ·á ¼­ºñ½º µîÀÇ ±â´ÉÀ» Áö¿øÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 446¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 547¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 1,861¾ï ´Þ·¯
CAGR(%) 22.60%

ÁÖ¿ä ¼ºÀå ¿äÀÎÀº ¿ø°Ý ÀÇ·á ¹× ÀÇ·á ITÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¿ø°Ý ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä¸¦ °¡¼ÓÈ­½ÃŲ Äڷγª19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ´õ¿í ¹ÚÂ÷¸¦ °¡Çß½À´Ï´Ù. ¶ÇÇÑ IoT ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü°ú ºñ¿ë È¿À²ÀûÀÎ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ½ÃÀå È®´ë¸¦ ÃËÁøÇß½À´Ï´Ù. ¶ÇÇÑ Ç¥ÁØ ÀÇ·á Á¤Ã¥ÀÇ ¼¼°èÈ­µµ ±¤¹üÀ§ÇÑ Ã¤ÅÃÀ» ÃËÁøÇÏ¿© ¼ö¿äÀÇ Àúº¯À» ³ÐÈ÷°í ÀÖ½À´Ï´Ù. ƯÈ÷, ÇコÄɾî ÀÎÇÁ¶ó°¡ ¹ßÀüÇϰí ÀÖ´Â ½ÅÈï ½ÃÀå¿¡¼­´Â Àúºñ¿ë, °íÁ¤¹Ð ±â±â¸¦ ¸ñÇ¥·Î ÇÏ´Â ½ÅÁ¦Ç° Ãâ½Ã°¡ °¡´ÉÇØ ºñÁî´Ï½º ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ º¸¾È¿¡ ´ëÇÑ ¿ì·Á, ±ÔÁ¦ Áؼö, °í°¡ÀÇ ±â±â ºñ¿ë µîÀÌ ¼ºÀå¿¡ Å« °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á¿Í µ¥ÀÌÅÍ À¯ÃâÀÇ À§ÇèÀº °­·ÂÇÑ Á¦¾à¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖÀ¸¸ç, °­·ÂÇÑ »çÀ̹ö º¸¾È ´ëÃ¥ÀÌ ÇÊ¿äÇÕ´Ï´Ù.

Çõ½Å ºÐ¾ß¿¡´Â ÀÇ»ç°áÁ¤À» °­È­Çϱâ À§ÇÑ ½Ç½Ã°£ µ¥ÀÌÅÍ ÅëÂû·Â°ú AI ±â¹Ý ¿¹Ãø ºÐ¼®À» Á¦°øÇÏ´Â º¸´Ù ÅëÇÕµÈ Ç÷§ÆûÀÇ °³¹ßÀÌ Æ÷ÇԵ˴ϴÙ. µð¹ÙÀ̽º ¹× Ç÷§Æû °£ »óÈ£¿î¿ë¼ºÀ» Ç¥ÁØÈ­ÇÏ·Á´Â ³ë·ÂÀº ½ÃÀåÀÇ ´ÜÆíÈ­¸¦ ±Øº¹ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ¼ÒÇÁÆ®¿þ¾î¿Í Çϵå¿þ¾î ±¸¼º¿ä¼Ò¸¦ ¿øÈ°ÇÏ°Ô ÅëÇÕÇϱâ À§ÇÑ ±â¼ú ±â¾÷°úÀÇ Çù¾÷Àº Å« ¼ºÀåÀ» °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ½ÃÀå ¿ªÇÐÀº ¿ªµ¿ÀûÀÌ°í °æÀïÀûÀ̱⠶§¹®¿¡ Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú Àü·«Àû ÆÄÆ®³Ê½Ê ±¸ÃàÀÌ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °Ç°­ ¹× ÇÇÆ®´Ï½º ¸ð´ÏÅ͸µÀ» À§ÇÑ ¿þ¾î·¯ºí ±â±â äÅÃ
    • °¡Ä¡ Áß½ÉÀÇ ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ´Ù¾çÇÑ m°Ç°­ ¾Û °³¹ß Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½º¸¶Æ® ÀÇ·á±â±âÀÇ ³ôÀº Á¦Á¶ ºñ¿ë
  • ½ÃÀå ±âȸ
    • ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ ºí·ÏüÀÎ ±â¼ú ¹× ÇコÄɾî¿Í ITÀÇ Çù¾÷ Áõ°¡
  • ½ÃÀå °úÁ¦
    • ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È¿¡ ´ëÇÑ ¿ì·Á

Portre's Five Forces: Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ·Â ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå °æÀï»óȲ ÆÄ¾Ç

Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ

Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå : Á¦Ç°º°

  • Ç÷¾Ð ¸ð´ÏÅÍ
  • ½ÉÀüµµ ¸ð´ÏÅ͸µ Àåºñ
  • Ç÷´ç ¸ð´ÏÅÍ
  • ½É¹Ú ¸ð´ÏÅÍ
  • Àν¶¸° ÆßÇÁ
  • ÈÞ´ë¿ë GPS PERS
  • ÆÞ½º¿Á½Ã¹ÌÅÍ
  • ½º¸¶Æ® ÇÊ µð½ºÆæ¼­

Á¦7Àå Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå : À¯Çüº°

  • Connected Capital-Intensive Device
  • Connected Physiological Monitor
  • Connected Wearable Medical Device

Á¦8Àå Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå : µð¹ÙÀ̽ºº°

  • ¿þ¾î·¯ºí ÀÌ¿Ü
  • ¿þ¾î·¯ºí

Á¦9Àå Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå : ¿ëµµº°

  • ¼ÒºñÀÚ ¸ð´ÏÅ͸µ
  • ³»ºÎ ÀÓº£µðµå µð¹ÙÀ̽º
  • °íÁ¤ µð¹ÙÀ̽º
  • ¿þ¾î·¯ºí µð¹ÙÀ̽º

Á¦10Àå Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ȨÄɾî ȯ°æ
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ä¿³ØÆ¼µå ÀÇ·á±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Abbott Laboratories
  • Aerotel Medical Systems Ltd.
  • AgaMatrix, Inc.
  • Boston Scientific Corporation
  • Cerner Corporation by Oracle Corporation
  • DexCom Inc.
  • F. Hoffmann-La Roche Ltd.
  • General Electric Company
  • iHealth Labs Inc.
  • Johnson & Johnson Private Limited
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Medtronic PLC
  • NXP Semiconductors N.V.
  • Omron Corporation
  • Smiths Group PLC
LSH

The Connected Medical Devices Market was valued at USD 44.69 billion in 2023, expected to reach USD 54.75 billion in 2024, and is projected to grow at a CAGR of 22.60%, to USD 186.10 billion by 2030.

Connected medical devices represent a transformative trend in healthcare, integrating technology with traditional medical devices to enhance the collection, transmission, and analysis of patient data. These devices collect and share health data via internet or cloud platforms, improving patient outcomes and facilitating personalized care. Their necessity arises from an increasing focus on remote patient monitoring, chronic disease management, and enhanced care quality, driven primarily by the rising aging population and the subsequent increase in chronic diseases. The end-use scope includes hospitals, healthcare providers, and home care settings, where these devices support functions such as continuous glucose monitoring, remote ECG, blood pressure tracking, and telehealth services.

KEY MARKET STATISTICS
Base Year [2023] USD 44.69 billion
Estimated Year [2024] USD 54.75 billion
Forecast Year [2030] USD 186.10 billion
CAGR (%) 22.60%

A key growth factor is the increasing adoption of telemedicine and health IT, further fueled by the COVID-19 pandemic, which accelerated the demand for remote monitoring. Additionally, the continuous advancements in IoT technologies and the desire for cost-effective healthcare solutions bolstered market expansion. The globalization of standard healthcare policies also supports broader adoption, widening the demand base. Opportunities exist particularly in emerging markets where healthcare infrastructure is evolving, offering potential for new product launches aimed at lower-cost, high-precision devices. However, challenges such as data security concerns, regulatory compliance, and high device costs pose substantial barriers to growth. Privacy concerns and the risk of data breaches are persistent limitations, requiring robust cybersecurity measures.

Innovation areas include developing more integrated platforms that offer real-time data insights and AI-driven predictive analytics to enhance decision-making. Efforts to standardize interoperability across devices and platforms are crucial to overcoming market fragmentation. Furthermore, collaboration with technology firms to ensure seamless integration of software and hardware components can yield substantial growth. Overall, the nature of the connected medical devices market is dynamic and competitive, necessitating continuous innovation and strategic partnerships to leverage technological advancements and emerging healthcare demands for sustainable business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Connected Medical Devices Market

The Connected Medical Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Adoption of wearable devices for health and fitness monitoring
    • Increasing demand of value-driven healthcare delivery services
    • Increase in the development of numerous mHealth apps
  • Market Restraints
    • High cost of manufacturing smart medical devices
  • Market Opportunities
    • Blockchain technology in healthcare and increasing healthcare-IT collaborations
  • Market Challenges
    • Privacy and security concerns

Porter's Five Forces: A Strategic Tool for Navigating the Connected Medical Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Connected Medical Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Connected Medical Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Connected Medical Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Connected Medical Devices Market

A detailed market share analysis in the Connected Medical Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Connected Medical Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Connected Medical Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Connected Medical Devices Market

A strategic analysis of the Connected Medical Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Connected Medical Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aerotel Medical Systems Ltd., AgaMatrix, Inc., Boston Scientific Corporation, Cerner Corporation by Oracle Corporation, DexCom Inc., F. Hoffmann-La Roche Ltd., General Electric Company, iHealth Labs Inc., Johnson & Johnson Private Limited, Koninklijke Philips N.V., McKesson Corporation, Medtronic PLC, NXP Semiconductors N.V., Omron Corporation, and Smiths Group PLC.

Market Segmentation & Coverage

This research report categorizes the Connected Medical Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across BP Monitor, ECG Monitoring Device, Glucose Monitor, Heart Rate Monitor, Insulin Pump, Portable GPS PERS, Pulse Oximeter, and Smart Pill Dispenser.
  • Based on Type, market is studied across Connected Capital-Intensive Device, Connected Physiological Monitor, and Connected Wearable Medical Device.
  • Based on Device, market is studied across Non-wearable and Wearable.
  • Based on Application, market is studied across Consumer Monitoring, Internally Embedded Device, Stationary Device, and Wearable Device.
  • Based on End-User, market is studied across Ambulatory Surgical Center, Home Care Setting, Hospital, and Specialty Clinic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Adoption of wearable devices for health and fitness monitoring
      • 5.1.1.2. Increasing demand of value-driven healthcare delivery services
      • 5.1.1.3. Increase in the development of numerous mHealth apps
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of manufacturing smart medical devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Blockchain technology in healthcare and increasing healthcare-IT collaborations
    • 5.1.4. Challenges
      • 5.1.4.1. Privacy and security concerns
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Connected Medical Devices Market, by Product

  • 6.1. Introduction
  • 6.2. BP Monitor
  • 6.3. ECG Monitoring Device
  • 6.4. Glucose Monitor
  • 6.5. Heart Rate Monitor
  • 6.6. Insulin Pump
  • 6.7. Portable GPS PERS
  • 6.8. Pulse Oximeter
  • 6.9. Smart Pill Dispenser

7. Connected Medical Devices Market, by Type

  • 7.1. Introduction
  • 7.2. Connected Capital-Intensive Device
  • 7.3. Connected Physiological Monitor
  • 7.4. Connected Wearable Medical Device

8. Connected Medical Devices Market, by Device

  • 8.1. Introduction
  • 8.2. Non-wearable
  • 8.3. Wearable

9. Connected Medical Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Consumer Monitoring
  • 9.3. Internally Embedded Device
  • 9.4. Stationary Device
  • 9.5. Wearable Device

10. Connected Medical Devices Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Center
  • 10.3. Home Care Setting
  • 10.4. Hospital
  • 10.5. Specialty Clinic

11. Americas Connected Medical Devices Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Connected Medical Devices Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Connected Medical Devices Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aerotel Medical Systems Ltd.
  • 3. AgaMatrix, Inc.
  • 4. Boston Scientific Corporation
  • 5. Cerner Corporation by Oracle Corporation
  • 6. DexCom Inc.
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. General Electric Company
  • 9. iHealth Labs Inc.
  • 10. Johnson & Johnson Private Limited
  • 11. Koninklijke Philips N.V.
  • 12. McKesson Corporation
  • 13. Medtronic PLC
  • 14. NXP Semiconductors N.V.
  • 15. Omron Corporation
  • 16. Smiths Group PLC
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦